Hans-Reiner Figulla
Hans-Reiner Figulla (* 25 July 1949 in Göttingen) is a German cardiologist, inventor and emeritus university professor.
Living[edit]
Hans R Figulla began his studies in economics at the University of Freiburg from 1968 to 1970. In 1971 Figulla started medicine at the Ludwig Maximilian University of Munich and at the Albert Ludwig University of Freiburg/Germany. Figulla obtained his medical doctor degree at the Institute of Physiology at the University of Freiburg under Albrecht Fleckenstein. After receiving his licensure in 1977as MD he worked as an Intern at St. Mary's Health Centre in St. Louis. Upon his return to Germany Figulla worked as a research scientist in the field of coronary microcirculation regulation at the Max Planck Institute for Systems Physiology in Dortmund for Dietrich W. Lübbers from 1978 to 1980. Figulla completed his training in internal medicine at the University Hospital in Göttingen from 1980 to 1986, followed by the subspecializing in the field of cardiology from 1986 to 1988. That same year Figulla received a PhD at the University Hospital Göttingen, soon after he was elected as Associate professor and Senior physician at the Department for Internal Medicine and Cardiology and senior physician at the University Hospital in Göttingen from 1988 to 1997, and was elected for the chair of Internal Medicine at the Friedrich Schiller University of Jena. Figulla became Professor and Director of the Clinic for Internal Medicine I (Cardiology, Angiology, Intensive Care Medicine) in 1997. He was co-founder of the University Heart Center Thuringia in 2007. He retired in 2015. He is presently working on the further development of catheter-guided heart valves in the companies he founded.
Inventions[edit]
Figulla is distinguished by inventions and the introduction of innovations in the field of interventional cardiology. Early as 1992 he published a book entitled: Circulatory support devices in interventional cardiology. He made first investigations and patent applications on percutaneous aortic valve replacement (TAVR) in 1995. A first publication on direct stent implantation in coronary artery disease was published in 1997; this publication was preceded by an invention for anchoring a coronary stent on the balloon catheter. Furthermore, various publications on the possibilities of percutaneous aortic valve replacement were published. He cofounded Occlutech and developed the Figulla-Occluder to close holes in the atrial septum of the heart in 2005. He cofounded JenaValve and developed a percutaneously implantable aortic valve of the same name in 2006. A new interventional concept for the treatment of tricuspid valve insufficiency was presented in 2011.
Awards and prizes[edit]
Figulla received the Sven-Effert Prize of the German Society of Cardiology for his developments and inventions in the field of cardiology in 2011. Together with his team, he has won the innovation prize of the Federal Ministry of Research and Technology four times. He was nominated by the Fraunhofer Society for the German Future Prize in 2008.
Publications and patents[edit]
A list of 502 publications is shown in PubMed.[1] Figulla is owner of 141 patents.
References[edit]
This article "Hans-Reiner Figulla" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Hans-Reiner Figulla. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
